Neurofibromatosis Type 1 Tumor Early Detection Study

Abroad (travel likely)Recruiting

Conditions

Neurofibromatosis Type 1 · Neurofibromatosis 1 · Plexiform Neurofibroma · Plexiform Neurofibromas · Malignant Peripheral Nerve Sheath Tumor · Malignant Peripheral Nerve Sheath Tumors · Atypical Neurofibroma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Boston Children's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (David T Miller, MD, PhD) · david.miller2@childrens.harvard.edu · 617-355-8221
Contact: Principal Investigator (David T Miller, MD, PhD)

Study leads

David T Miller, MD, PhD
Principal Investigator
Boston Children's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

NF1 · Neurofibromatosis · Cutaneous Neurofibroma

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

Neurofibromatosis Type 1 · Neurofibroma

Abroad (travel likely)Recruiting

Bethesda, United States

Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1

Neurofibroma · Neurofibroma, Plexiform

Abroad (travel likely)Recruiting

Lyon, France

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Neurofibromatosis 1 · Plexiform Neurofibromas

Abroad (travel likely)Recruiting

Washington D.C., United States · Chicago, United States